ClinicalTrials.Veeva

Menu

Oral and Systemic aMMP-8 in Periodontal Disease

A

Aydin Adnan Menderes University

Status

Completed

Conditions

Periodontal Diseases
Periodontal Inflammation

Treatments

Other: Biochemical analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04268381
20-2T/39

Details and patient eligibility

About

Periodontal disease is an inflammatory process that can result in tooth loss and also is considered a modifying factor for systemic health. Matrix metalloproteinase (MMP)-8 is the major collagenase of periodontal tissue breakdown. The aim of the present study is to analyze active (aMMP-8) levels in gingival crevicular fluid (GCF), saliva and serum in the context of new criteria of gingivitis and stage 3 grade C periodontitis.

Enrollment

83 patients

Sex

All

Ages

25 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • systemically healthy and non-smoker individuals aged 25 to 50 years
  • having ≥20 teeth present (except third molars)
  • individuals with periodontally healthy, gingivitis and stage 3 periodontitis diagnoses

Exclusion criteria

  • having any systemic disease
  • smoking
  • pregnancy or lactation
  • using antibiotic or any anti-inflammatory drug or any periodontal treatment within the past 6 months.

Trial design

83 participants in 3 patient groups

Healthy (n=23)
Treatment:
Other: Biochemical analysis
Gingivitis (n=20)
Treatment:
Other: Biochemical analysis
Periodontitis (n=40)
Treatment:
Other: Biochemical analysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems